Drug
Vamifeport Irf
Vamifeport Irf: highest development phase Phase 1, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vamifeport IRF NCT06726863 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Vamifeport Irf on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.